Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Protagonist Therapeutics Q3 EPS $(0.64) Up From $(0.70) YoY

Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.64) per share. This is a 8.57 percent increase over losses of $(0.70) per share from the same period last year.
byBenzinga Newsdesk
November 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.64) per share. This is a 8.57 percent increase over losses of $(0.70) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts